Rhumbline Advisers Eargo, Inc. Transaction History

Rhumbline Advisers

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.75 - $5.6 $21,129 - $157,763	-28,172 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$3.3 - $7.28 $29,221 - $64,464	8,855 Added 45.84%	28,172 $149,000
Q4 2021 Feb 10, 2022	BUY	$4.6 - $10.21 $4,876 - $10,822	1,060 Added 5.81%	19,317 $99,000
Q3 2021 Nov 12, 2021	BUY	$6.59 - $38.71 $5,779 - $33,948	877 Added 5.05%	18,257 $123,000
Q2 2021 Aug 05, 2021	BUY	$32.1 - $57.78 $317,340 - $571,213	9,886 Added 131.92%	17,380 $694,000
Q1 2021 May 06, 2021	BUY	$42.5 - $75.37 $17,680 - $31,353	416 Added 5.88%	7,494 $374,000
Q4 2020 Feb 10, 2021	BUY	$33.49 - $57.94 $237,042 - $410,099	7,078 New	7,078 $317,000

33.4K

Ticker EAR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,411,000
Market Cap $2.78B
Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.